Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Bioengineered Protein Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024


 

Available formats:    

StumbleUponEmail

Global Bioengineered Protein Drugs Market

 

By Drug Type (Vaccines, Peptide hormones, Blood Products, Monoclonal antibodies, Recombinant protein drugs, Replacement proteins, Peptide antibiotics, Therapeutic enzymes, Cytokines), By Technology (Bioreactors and microbial cell fermentation, Genetically modified organisms, Fractionation, Pharming, Others), By Application (Diabetes, Heart diseases, Neurodegenerative diseases, Respiratory diseases, Infectious diseases, Congenital diseases, Others), By Drug delivery (Traditional methods, Novel Methods), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global bioengineered protein drugs market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024

 

Market Outline: Bioengineered Protein Drugs Market

Bioengineered proteins are formulated as the fundamental participants in the biological process. They are target specific and have lesser side effects which leads to higher acceptance when compared to that of a small molecule. The bioengineered proteins act as the powerful therapeutic agents. They include a wide range of products such as monoclonal antibodies, cytokines, growth factors, and many. Due to various factors such as bio-reactivity, safety, and success rate bioengineered proteins are gaining popularity all across the healthcare industry.

 

Market Dynamics: Bioengineered Protein Drugs Market

Increase in prevalence of chronic diseases such as diabetics, cancer etc. is one of the major factor responsible for the growth of the bioengineered protein drugs market. According to the WHO, the diabetic population is expected to grow by 366 million by 2030. The technological advancements in the drug delivery system and noticeable manufacturing developments in the biopharmaceutical industry is likely to drive the growth of the bioengineered protein drugs market over the forecast period. The minimal side effects of the bioengineered protein drugs also boosting the growth of the market. However, the higher cost of the drugs is likely to hamper the growth of the market.

 

Market Scope: Bioengineered Protein Drugs Market

Bioengineered protein drugs market is segmented on the basis of drug type, technology, application, and by drug delivery.

Based on the drug type, the market is segmented into the following:

  • Vaccines
    • Subunit/Conjugate
    • Toxoid
    • Live Attenuated Vaccines
    • Inactivated/Killed Vaccines
  • Peptide Hormones
    • Growth Hormones
    • Erythropoietin
    • Insulin
    • Luteinizing Hormones
    • Follicle Stimulating Hormones
  • Blood Products
    • Coagulation Factors
    • Thrombin
    • Immune Globulins
    • C1 Esterase Inhibitor
    • Alpha 1-Protease Inhibitor
    • Antithrombin
  • Monoclonal Antibodies
  • Recombinant Protein Drugs
  • Replacement Proteins
  • Peptide Antibiotics
  • Therapeutic Enzymes
    • Metabolic Enzymes
    • Digestive Enzymes
    • Others
  • Cytokines
    • Interferons
    • Interleukins
    • Colony stimulating factors

Based on the technology, the market is segmented into the following:

  • Bioreactors and Microbial Cell Fermentation
  • Genetically Modified Organisms
  • Fractionation
  • Pharming
  • Others

Based on the application, the market is segmented into the following:

  • Diabetes
  • Heart Diseases
  • Neurodegenerative Diseases
  • Respiratory Diseases
  • Infectious Diseases
  • Congenital Diseases
  • Others

Based on the drug delivery, the market is segmented into the following:

  • Traditional methods
  • Novel Methods

 

Regional Analysis:  Bioengineered Protein Drugs Market

Geographically, global bioengineered protein drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America bioengineered protein drugs market holding larger revenue share when compared with that of the other markets. The growing technological advanced products, developed research sector are driving the growth of the bioengineered protein drugs market in North America region. The growing awareness among the people about chronic diseases and the higher adoption of the new drugs is also responsible for the growth of the market in this region. The Asia Pacific region expected to grow at significant rate owing to expansion of the biopharmaceutical industries in the region. The developing economic scenario is showing scope for the development of R&D activities in this region.

 

Competition Assessment: Bioengineered Protein Drugs Market

Some of the players in the global bioengineered protein drugs market include:

  • Abbott Laboratories (U.S)
  • Amgen (U.S)
  • KEDRION BIOPHARMA (U.S)
  • Merck & Co., Inc. (U.S)
  • Allergan (Ireland)
  • Eli Lilly and Company (U.S)
  • Johnson & Johnson (U.S)
  • Panacea Biotec (India)
  • GlaxoSmithKline plc (U.K)
  • Hoffmann-La Roche (Switzerland)

 

Notable Market Developments: Bioengineered Protein Drugs Market

  • In August 2017, Kedrion Biopharma and Kamada Ltd. has received U.S. Food and Drug Administration (FDA) approval for KEDRAB™ [rabies immune globulin (Human)], for passive, transient post-exposure prophylaxis of rabies infection, when given immediately after contact with a rabid or possibly rabid animal.

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Abbott Laboratories (U.S)
  • Amgen (U.S)
  • KEDRION BIOPHARMA (U.S)
  • Merck & Co., Inc. (U.S)
  • Allergan (Ireland)
  • Eli Lilly and Company (U.S)
  • Johnson & Johnson (U.S)
  • Panacea Biotec (India)
  • GlaxoSmithKline plc (U.K)
  • Hoffmann-La Roche (Switzerland)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553